Epilepsy Drug Sulthiame Shows Promise Against Obstructive Sleep Apnoea

Tuesday, 10 September 2024, 05:15

Epilepsy drug Sulthiame can significantly reduce symptoms of obstructive sleep apnoea. Swedish experts report a 40% reduction in symptoms among patients taking the drug compared to those on placebo. This breakthrough highlights potential benefits of repurposing medications for sleep disorders.
LivaRava_Medicine_Default.png
Epilepsy Drug Sulthiame Shows Promise Against Obstructive Sleep Apnoea

Significant Findings on Sulthiame and Sleep Apnoea

Recent research conducted by Swedish professionals reveals exciting potential for the epilepsy drug Sulthiame in treating obstructive sleep apnoea. The study indicates that patients using Sulthiame experienced an astounding 40% reduction in symptoms when compared to those administered a placebo.

Exploring the Implications

This discovery prompts further investigation into how medications designed for epilepsy might also alleviate symptoms of severe sleep disorders. It opens new avenues for treating complications associated with sleep apnoea that affects millions worldwide.

  • Sulthiame as an anti-epileptic drug
  • Potential for patient repurposing
  • Impact on nocturnal breathing

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe